Browse by Journal Title

2014

Role of CYP1A1 in modulating the vascular and blood pressure benefits of omega-3 polyunsaturated fatty acids.
Agbor, L.N., Wiest, E.F., Rothe, M., Schunck, W.H. and Walker, M.K.
Journal of Pharmacology and Experimental Therapeutics 351 (3): 688-698. December 2014

The biological actions of 11,12-epoxyeicosatrienoic acid in endothelial cells are specific to the R/S-enantiomer and require the G(s) protein.
Ding, Y., Froemel, T., Popp, R., Falck, J.R., Schunck, W.H. and Fleming, I.
Journal of Pharmacology and Experimental Therapeutics 350 (1): 14-21. July 2014

2005

(+)-Norfenfluramine-induced arterial contraction is not dependent on endogenous 5-HT or 5-HTT.
Ni, W., Wilhelm, C.S., Bader, M., Murphy, D.L., Lookingland, K.J. and Watts, S.W.
Journal of Pharmacology and Experimental Therapeutics 314 (3): 953-960. 18 May 2005

1998

Calcium-activated potassium channels and nitrate-induced vasodilation in human coronary arteries.
Bychkov, R., Gollasch, M., Steinke, T., Ried, C., Luft, F.C. and Haller, H.
Journal of Pharmacology and Experimental Therapeutics 285 : 293-298. 1 January 1998

1997

Body distribution of free, liposomal and nanoparticle-associated mitoxantrone in B16-melanoma-bearing mice.
Reszka, R., Beck, P., Fichtner, I., Hentschel, M., Richter, J. and Kreuter, J.
Journal of Pharmacology and Experimental Therapeutics 280 : 232-237. 1 January 1997

1995

Angiotensin II type I receptor antagonist inhibits the gene expression of transforming growth factor-beta1 and extracellular matrix in cardiac and vascular tissues of hypertensive rats.
Kim, S.K., Ohta, K., Hamaguchi, A., Omura, T., Yukimura, T., Miura, K., Inada, Y., Ishimura, Y., Chatani, F. and Iwao, H.
Journal of Pharmacology and Experimental Therapeutics 273 (1): 509-515. April 1995

Pinacidil relaxes porcine and human coronary arteries by activating atp-dependent potassium channels in smooth muscle cells.
Gollasch, M., Bychkov, R., Ried, C., Behrendt, F., Scholze, S., Luft, F.C. and Haller, H.
Journal of Pharmacology and Experimental Therapeutics 275 (2): 681-692. 1 January 1995

1994

Inotropic effect of the cardioprotective agent 2,3- butanedione monoxime in failing and nonfailing human myocardium.
Schwinger, R.H.G., Boehm, M., Koch, A., Morano, I., Rueegg, J.C. and Erdmann, E.
Journal of Pharmacology and Experimental Therapeutics 269 : 778-786. 1 January 1994